Company
Medacta
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
160
510(k), De Novo and PMA
Device trials
43
As lead sponsor, any status
Adverse event reports
1,399
Received Nov 1, 2025 to Nov 20, 2026
Recall records
23
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Medacta, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Medacta.
Latest FDA decisions
The 8 newest of 160 since 2015.
K260173 · Decided Sep 17, 2026 · 239 days after receipt
Device type: Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented (LZO) · Orthopedic Surgery
- GMK Extension510(k)
K262057 · Decided Sep 15, 2026 · 89 days after receipt
Device type: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer (JWH) · Orthopedic Surgery
- Mpact 3D Metal Foam510(k)
K253630 · Decided Aug 28, 2026 · 282 days after receipt
Device type: Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented (LPH) · Orthopedic Surgery
157 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT02748408 · 550 participants (planned) · Start Jul 2015 · Primary completion Jul 2032
Device: SMS femoral stem · For: Arthrosis; Traumatic Arthritis; Rheumatoid Polyarthritis and 2 more
Sites: Vienna, Austria; Milan, Italy; Solothurn, Switzerland · 4 sites in all
- The Medacta Quadra-P Anteverted StudyActive, not recruiting
NCT05460715 · 300 participants (planned) · Start Jul 30, 2021 · Primary completion Jul 2032
Device: Quadra P anteverted · For: Arthrosis; Traumatic Arthritis; Rheumatoid Polyarthritis and 2 more
Sites: Messina, Italy
- Mpact 3D Metal Monolit StudyRecruiting
NCT06748885 · 88 participants (planned) · Start Feb 28, 2024 · Primary completion Dec 2030
Device: Mpact 3D Metal Monolith · For: Total Hip Arthroplasty (THA)
Sites: Nantes, France; Paris, France · 3 sites in all
40 more trials with a free account
Reports received
1,399
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
90
6.4% of reports
Injury reports
1,308
93% of reports
Death reports
1
0.1% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 4 | 122 | 0 | 0 |
| Jan 24 | 3 | 84 | 0 | 0 |
| Feb 24 | 3 | 58 | 0 | 0 |
| Mar 24 | 3 | 81 | 0 | 0 |
| Apr 24 | 10 | 94 | 0 | 0 |
| May 24 | 7 | 99 | 0 | 0 |
| Jun 24 | 3 | 101 | 0 | 0 |
| Jul 24 | 2 | 105 | 0 | 0 |
| Aug 24 | 3 | 102 | 0 | 0 |
| Sep 24 | 8 | 83 | 0 | 0 |
| Oct 24 | 9 | 113 | 0 | 0 |
| Nov 24 | 7 | 92 | 0 | 0 |
| Dec 24 | 3 | 120 | 0 | 0 |
| Jan 25 | 4 | 68 | 0 | 0 |
| Feb 25 | 3 | 114 | 0 | 0 |
| Mar 25 | 17 | 95 | 0 | 0 |
| Apr 25 | 5 | 104 | 0 | 0 |
| May 25 | 4 | 133 | 0 | 0 |
| Jun 25 | 8 | 91 | 0 | 0 |
| Jul 25 | 13 | 132 | 0 | 0 |
| Aug 25 | 5 | 76 | 0 | 0 |
| Sep 25 | 2 | 103 | 1 | 0 |
| Oct 25 | 7 | 112 | 0 | 0 |
| Nov 25 | 11 | 141 | 0 | 0 |
| Dec 25 | 1 | 133 | 0 | 0 |
| Jan 26 | 6 | 64 | 1 | 0 |
| Feb 26 | 3 | 75 | 0 | 0 |
| Mar 26 | 7 | 125 | 0 | 0 |
| Apr 26 | 3 | 89 | 0 | 0 |
| May 26 | 10 | 150 | 0 | 0 |
| Jun 26 | 10 | 67 | 0 | 0 |
| Jul 26 | 15 | 168 | 0 | 0 |
| Aug 26 | 6 | 77 | 0 | 0 |
| Sep 26 | 7 | 68 | 0 | 0 |
| Oct 26 | 11 | 151 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
- Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented (LZO)326
7 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2618-2026 · Started Apr 30, 2026 · Posted by FDA Jun 29, 2026
Reason given: Surgical instruments used during shoulder arthroplasty procedures does not progressively translate to replicate implant geometry, so the reaming guide and the stem reamer are positioned approximately 0.2 mm per size more laterally than intended, which may increase the risk of fracture in the medial region of the...
Cause as FDA categorized it: Device Design · Device type: Shoulder Prosthesis, Reverse Configuration (PHX)
Z-1400-2023 · Started Mar 8, 2023 · Posted by FDA Apr 19, 2023
Reason given: There is a potential for breakage of the small screw used to affix the anti-backout plate.
Cause as FDA categorized it: Under Investigation by firm · Device type: Intervertebral Fusion Device With Integrated Fixation, Lumbar (OVD)
Z-1401-2023 · Started Mar 8, 2023 · Posted by FDA Apr 19, 2023
Reason given: There is a potential for breakage of the small screw used to affix the anti-backout plate.
Cause as FDA categorized it: Under Investigation by firm · Device type: Intervertebral Fusion Device With Integrated Fixation, Lumbar (OVD)
20 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.